ASR Guidance Development May Be Supported By AdvaMed FAQ Document

AdvaMed plans to revise a set of frequently asked questions related to analyte specific reagents that could be used as a starting point for an FDA guidance document, following a recent meeting with the agency

More from Archive

More from Medtech Insight